Scholars Central

Conference abstractPublished 13 Nov 2019

Novel stability indicating LC methods for determination of tasimelteon

Authors: Serkan Levent, Saniye Ozcan, Aysun Geven, Yusuf Ozkay, Nafiz Oncu Can

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Tasimelteon (TAS) is a melatonin receptor agonist compound, which is currently in use for the treatment of non-24-hour sleepâÂ?Â?wake disorder in totally blind people. In this study, novel stability-indicating LC methods have been developed for the determination of TAS besides its degradation products. Three different LC set-ups were used within this study. Initially, an LC-PDA instrument was developed for quantification of TAS; the separation of TAS from its degradation products was achieved on an Ascentis® Express F5-bonded fused-core silica particle column using the mobile phase of acetonitrile: acetate buffer (0.025 M, pH 4.5): water (40:10:50, v/v/v); the elution was performed in isocratic mode at 0.8 mL minâÂ?Â?1 flow rate, detecting the analytes at 281 nm. In addition, an alternative method was developed by using an LC-DAD-MS/MS instrument; the responses of DAD and MS/ MS detectors were used as separate analytical signals for TAS and other compounds. A second-generation C18-bonded monolithic silica column was used as stationary phase in this method, while the mobile phase was a mixture of 0.1% (v/v) formic acid in water and 0.1% (v/v) formic acid in acetonitrile (60: 40 (v/v), pH=2.5). The instrumental and analytical performances of all three set-ups were compared in terms of validation parameters mentioned in ICHQ2(R1) guideline. On the other hand, a new degradation product was identified using an LC/MS-IT-TOF instrument. In conclusion, determination of TAS besides its degradation products and identification of a novel degradation product was successfully performed using the protocols reported in this study.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Research & Reviews: Journal of Pharmaceutical Analysis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalResearch & Reviews: Journal of Pharmaceutical Analysis
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Serkan Levent”
  • BylineArticles whose byline prints “Saniye Ozcan”
  • BylineArticles whose byline prints “Aysun Geven”
  • BylineArticles whose byline prints “Yusuf Ozkay”
  • BylineArticles whose byline prints “Nafiz Oncu Can”